Edit

Presidio Partners

https://presidiopartners.com/
Last activity: 06.05.2022
Active
Invests in categories: CenterDrugEnergyTechFinTechLogisticsMedTechPlatformProductServiceTechnology
News
69
Portfolio
31
Mentions
4
Employees: 1-10
Investment Type: Venture Capital

Portfolio 31

DateNameWebsiteTotal RaisedLocation
-Beautylishbeautylish.com-United Sta...
-CNano Tech...cnanotechnology.com$21M-
-Arista Net...mojonetworks.com$30MUnited Sta...
-TelStratserenova.com-United Sta...
-Zipmark, I...zipmark.com$3.5MUnited Sta...
-Ambrxambrx.com$297MUnited Sta...
-Untangleuntangle.com$8MUnited Sta...
-Ardelyxardelyx.com$82.5MUnited Sta...
-Zaarlyzaarly.com$14.1M-
-Teva Pharm...auspexpharma.com$35MIsrael, Te...
Show more

News 69

DateTitleDescription
23.09.2021Investments in Exela Pharma Sciences to secure & support U.S based drug supply & manufacturing-
08.06.2020Solaria Corporation Unveils World Class Executive Team-
01.04.2020Altimmune Completes First Development Milestone Toward A Single-Dose Intranasal COVID-19 Vaccine-
19.03.2020Lifesize and Serenova Merge-
07.12.2019Ardelyx receives FDA approval-
07.12.2019Solaria Raises $40M to Double Its Module Production Capacity-
07.12.2019Wildcat raises more than $20M Series C financing-
14.09.2019Altimmune Announces Closing of Acquisition of Spitfire Pharma-
07.08.2018Inventure Renewables, Wilmar and Desmet Ballestra Announce Agreement to Build New Plant-
02.08.2018Arista Acquires Mojo Networks-
Show more

Mentions in press and media 4

DateTitleDescription
18.07.2017Rock Springs Capital Joins $50M Series C for Menlo TherapeuticsMenlo Therapeutics Inc. announced today that the company has raised $50M to advance development of serlopitant, a novel NK-1 receptor antagonist, as a once-daily oral treatment for pruritus (itch) associated with atopic dermatitis, psoriasi...
18.07.2017F-Prime Capital Joins $50M Series C for Menlo TherapeuticsMenlo Therapeutics Inc. announced today that the company has raised $50M to advance development of serlopitant, a novel NK-1 receptor antagonist, as a once-daily oral treatment for pruritus (itch) associated with atopic dermatitis, psoriasi...
02.12.2015Marlin Equity Partners and Presidio Partners Buy LiveOpsLiveOps, an Austin, Texas-based provider of SaaS-based cloud contact center and customer service solutions, has been acquired by global investment firm Marlin Equity Partners. Venture capital firm Presidio Partners, an existing investor in ...
21.04.2015Presidio Partners Announces New Fund and New Corporate IdentitySan Francisco-based venture capital firm Presidio Partners (formerly CMEA Capital) announced its corporate identity. The firm has just announced the closing of Presidio Partners 2014, a new $142m fund focused on information technology, life...

Reviews 0

Sign up to leave a review

Sign up Log In